CN104507917B - 用于制造艾沙康唑或雷夫康唑的方法 - Google Patents

用于制造艾沙康唑或雷夫康唑的方法 Download PDF

Info

Publication number
CN104507917B
CN104507917B CN201380038886.2A CN201380038886A CN104507917B CN 104507917 B CN104507917 B CN 104507917B CN 201380038886 A CN201380038886 A CN 201380038886A CN 104507917 B CN104507917 B CN 104507917B
Authority
CN
China
Prior art keywords
formula
mixture
ester
amino acid
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380038886.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN104507917A (zh
Inventor
萨莫伦 R·范
H·瓦森
D·明克
M·瓦瑟尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basilea Pharmaceutica AG
Original Assignee
Basilea Pharmaceutica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica AG filed Critical Basilea Pharmaceutica AG
Publication of CN104507917A publication Critical patent/CN104507917A/zh
Application granted granted Critical
Publication of CN104507917B publication Critical patent/CN104507917B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Enzymes And Modification Thereof (AREA)
CN201380038886.2A 2012-08-07 2013-07-31 用于制造艾沙康唑或雷夫康唑的方法 Active CN104507917B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12179540.5 2012-08-07
EP12179540 2012-08-07
PCT/EP2013/066071 WO2014023623A1 (en) 2012-08-07 2013-07-31 Process for the manufacture of isavuconazole or ravuconazole

Publications (2)

Publication Number Publication Date
CN104507917A CN104507917A (zh) 2015-04-08
CN104507917B true CN104507917B (zh) 2017-10-17

Family

ID=48979725

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380038886.2A Active CN104507917B (zh) 2012-08-07 2013-07-31 用于制造艾沙康唑或雷夫康唑的方法

Country Status (15)

Country Link
US (2) US9783508B2 (enExample)
EP (1) EP2882723B1 (enExample)
JP (1) JP6334529B2 (enExample)
KR (1) KR102129150B1 (enExample)
CN (1) CN104507917B (enExample)
BR (1) BR112015002526B1 (enExample)
CA (1) CA2878361C (enExample)
ES (1) ES2616412T3 (enExample)
HR (1) HRP20170171T1 (enExample)
HU (1) HUE031679T2 (enExample)
MX (1) MX360783B (enExample)
PL (1) PL2882723T3 (enExample)
PT (1) PT2882723T (enExample)
SI (1) SI2882723T1 (enExample)
WO (1) WO2014023623A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105801500B (zh) * 2014-12-31 2018-08-24 四川科伦药物研究院有限公司 拆分艾沙康唑中间化合物消旋体的方法
CN106317044A (zh) * 2015-06-30 2017-01-11 刘玫君 一种制造艾沙康唑或雷夫康唑的方法
CN104961695A (zh) * 2015-07-27 2015-10-07 成都塞恩斯医药科技有限公司 一种艾沙康唑和雷夫康唑中间体的制备方法
CN106467534B (zh) * 2015-08-17 2019-10-11 江苏奥赛康药业有限公司 一种硫酸艾沙康唑鎓化合物及其药物组合物
CN105907832B (zh) * 2015-12-02 2019-07-12 成都师范学院 一种酶法拆分艾沙康唑中间体的方法
CN108452848B (zh) * 2016-02-24 2020-12-11 上海兰立生物科技有限公司 一种催化剂
WO2018200214A2 (en) * 2017-04-27 2018-11-01 Codexis, Inc. Ketoreductase polypeptides and polynucleotides
WO2021245590A1 (en) * 2020-06-04 2021-12-09 Metrochem Api Private Limited An improved process for the preparation of triazole derivatives
CN111574444A (zh) * 2020-07-07 2020-08-25 安徽贝克生物制药有限公司 一种贝达喹啉的制备方法
CN116478103B (zh) * 2023-03-24 2025-07-25 四川澄华生物科技有限公司 一种拆分艾沙康唑中间体4的方法
CN119661453B (zh) * 2025-02-17 2025-04-22 四川澄华生物科技有限公司 一种制备艾沙康唑的主链中间体的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510195D0 (en) * 1985-04-22 1985-05-30 Ici Plc Heterocyclic compounds
US5134152A (en) 1989-12-07 1992-07-28 Sankyo Company, Limited Oxetane derivatives and their use as anti-fungal or fungicidal agents
JP2887523B2 (ja) * 1990-11-30 1999-04-26 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩
GB9107055D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
JP4208269B2 (ja) * 1996-10-01 2009-01-14 東芝ソリューション株式会社 異種物混入検査方法及びそのシステム
AU7937998A (en) 1997-07-08 1999-02-08 Sankyo Company Limited Antifungal triazole compounds
WO1999045008A1 (en) 1998-03-06 1999-09-10 F. Hoffmann-La Roche Ag 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity
MXPA03010914A (es) 2001-06-26 2004-02-17 Basilea Pharmaceutica Ag DERIVADOS DE HALOFENILO INTERMEDIARIOS Y SU USO EN UN PROCESO PARA LA PREPARACIoN DE DERIVADOS DE AZOL.
WO2007062542A2 (en) 2005-12-01 2007-06-07 Basilea Pharmaceutica Ag Process for the manufacture of epoxybutanol intermediates
GB0712972D0 (en) 2007-07-04 2007-08-15 Glaxosmithkline Consumer Healt Formulation
ES2652559T3 (es) 2007-07-04 2018-02-05 Dpx Holdings B.V. Preparación de una esterasa
CN102344457B (zh) 2007-09-12 2015-07-22 杏林制药株式会社 作为 gsk-3 抑制剂的螺环状氨基喹诺酮
EP2289868B1 (en) 2008-06-25 2014-08-13 Daiichi Sankyo Company, Limited Carboxylic acid compound
SI2298747T1 (sl) * 2008-07-03 2017-08-31 Astellas Pharma Inc. Derivat triazola ali njegova sol
US8921080B2 (en) 2009-04-24 2014-12-30 Dsm Ip Assets B.V. Pig liver esterases
US8207352B2 (en) * 2009-10-08 2012-06-26 Drug Process Licensing Associates LLC Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole
WO2011145669A1 (ja) * 2010-05-19 2011-11-24 大日本住友製薬株式会社 アミド誘導体

Also Published As

Publication number Publication date
JP6334529B2 (ja) 2018-05-30
KR20150037875A (ko) 2015-04-08
CA2878361A1 (en) 2014-02-13
CN104507917A (zh) 2015-04-08
PT2882723T (pt) 2017-02-23
EP2882723A1 (en) 2015-06-17
WO2014023623A1 (en) 2014-02-13
KR102129150B1 (ko) 2020-07-02
ES2616412T3 (es) 2017-06-13
US20150239852A1 (en) 2015-08-27
US9783508B2 (en) 2017-10-10
BR112015002526A2 (pt) 2018-06-12
MX2015000744A (es) 2015-04-14
US20190077771A1 (en) 2019-03-14
EP2882723B1 (en) 2016-11-16
MX360783B (es) 2018-11-16
JP2015527345A (ja) 2015-09-17
BR112015002526B1 (pt) 2022-09-06
CA2878361C (en) 2020-09-22
PL2882723T3 (pl) 2017-05-31
HRP20170171T1 (hr) 2017-04-07
SI2882723T1 (sl) 2017-04-26
HUE031679T2 (en) 2017-07-28
US10590092B2 (en) 2020-03-17

Similar Documents

Publication Publication Date Title
CN104507917B (zh) 用于制造艾沙康唑或雷夫康唑的方法
US9061991B2 (en) Method for producing 1-amino-1-alkoxycarbonyl-2-vinylcyclopropane
US20140018577A1 (en) Process for Preparing Lacosamide
CA2449836C (fr) Preparation stereoselective de l-acides amines cycliques
CN103228640A (zh) 奈必洛尔的制备过程
CN110343734B (zh) 一种l-草铵膦化学酶法生产方法
KR101565439B1 (ko) 시타글립틴의 합성을 위한 전구체인 베타아미노산을 포함한 다양한 광학활성 베타아미노산의 효소적 생산 방법
JP3140549B2 (ja) α−置換カルボン酸の光学異性体の分離法
WO2004104205A2 (en) Enzymatic preparation of chiral indole esters
US20210087592A1 (en) Enzymatic processes for the preparation of (±)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (±)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid
WO2017092197A1 (zh) 一种艾沙康唑中间体的酶法拆分方法
WO2019189724A1 (ja) 新規加水分解酵素及びそれを利用した(1s,2s)-1-アルコキシカルボニル-2-ビニルシクロプロパンカルボン酸の製造方法
TWI595093B (zh) 從β-內酯酵素製造肉毒鹼之方法
JP5329973B2 (ja) リパーゼ触媒を用いるエナンチオ選択的アシル化とその後の硫酸による沈殿によって、ラセミ体の4−(1−アミノエチル)安息香酸メチルエステルから(r)−および(s)−4−(1−アンモニウムエチル)安息香酸メチルエステル硫酸塩を調製する方法
JPWO2008129873A1 (ja) S体選択性フェニルアラニンアミノムターゼ、これをコードするDNA及び(S)−β−フェニルアラニンの製造方法並びに(S)−β−フェニルアラニン類似体の製造方法
JP2002306194A (ja) 光学活性シアンヒドリンの製造方法
WO2005038036A1 (fr) Procede de transformation d'epoxydes porteurs de groupes trifluoromethyle
WO2008072764A1 (ja) 光学活性(r又はs)-ピペリジン-3-カルボン酸化合物及び光学活性(s又はr)-ピペリジン-3-カルボン酸アルキルエステル化合物の製造方法
JP2012193135A (ja) アミノ酸の製造方法
JP2013255505A (ja) 光学活性アミノ酸及びn−アルコキシカルボニルアミノ酸類の製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant